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Association of a Frailty Screening Initiative With
Postoperative Survival at 30, 180, and 365 Days
Daniel E. Hall, MD, MDiv, MHSc; Shipra Arya, MD, SM; Kendra K. Schmid, PhD; Mark A. Carlson, MD;
Pierre Lavedan, MD; Travis L. Bailey, BS; Georgia Purviance, RN; Tammy Bockman, RN, MHA;
Thomas G. Lynch, MD, MHCM; Jason M. Johanning, MD, MS

IMPORTANCE As the US population ages, the number of operations performed on elderly
patients will likely increase. Frailty predicts postoperative mortality and morbidity more than
age alone, thus presenting opportunities to identify the highest-risk surgical patients and
improve their outcomes.

Invited Commentary
page 240

OBJECTIVE To examine the effect of the Frailty Screening Initiative (FSI) on mortality and

complications by comparing the surgical outcomes of a cohort of surgical patients treated
before and after implementation of the FSI.
DESIGN, SETTING, AND PARTICIPANTS This single-site, facility-wide, prospective cohort quality
improvement project studied all 9153 patients from a level 1b Veterans Affairs medical center
who presented for major, elective, noncardiac surgery from October 1, 2007, to July 1, 2014.
INTERVENTIONS Assessment of preoperative frailty in all patients scheduled for elective

surgery began in July 2011. Frailty was assessed with the Risk Analysis Index (RAI), and the
records of all frail patients (RAI score, ⱖ21) were flagged for administrative review by the
chief of surgery (or designee) before the scheduled operation. On the basis of this review,
clinicians from surgery, anesthesia, critical care, and palliative care were notified of the
patient’s frailty and associated surgical risks; if indicated, perioperative plans were modified
based on team input.
MAIN OUTCOMES AND MEASURES Postoperative mortality at 30, 180, and 365 days.
RESULTS From October 1, 2007, to July 1, 2014, a total of 9153 patients underwent surgery

(mean [SD] age, 60.3 [13.5] years; female, 653 [7.1%]; and white, 7096 [79.8%]). Overall
30-day mortality decreased from 1.6% (84 of 5275 patients) to 0.7% (26 of 3878 patients,
P < .001) after FSI implementation. Improvement was greatest among frail patients (12.2%
[24 of 197 patients] to 3.8% [16 of 424 patients], P < .001), although mortality rates also
decreased among the robust patients (1.2% [60 of 5078 patients] to 0.3% [10 of 3454
patients], P < .001). The magnitude of improvement among frail patients increased at 180
(23.9% [47 of 197 patients] to 7.7% [30 of 389 patients], P < .001) and 365 days (34.5% [68
of 197 patients] to 11.7% [36 of 309 patients], P < .001). Multivariable models revealed
improved survival after FSI implementation, controlling for age, frailty, and predicted
mortality (adjusted odds ratio for 180-day survival, 2.87; 95% CI, 1.98-4.16).
CONCLUSIONS AND RELEVANCE Implementation of the FSI was associated with reduced
mortality, suggesting the feasibility of widespread screening of patients preoperatively to
identify frailty and the efficacy of system-level initiatives aimed at improving their surgical
outcomes. Additional investigation is required to establish a causal connection.
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M

any patients older than 65 years undergo surgery.1
For some, surgery will confer substantial benefits (eg,
extended life, improved quality of life). For others,
surgery will confer burdens for patients, families, and society
at large (eg, pain, distress, increased inpatient admissions, institutionalization, financial hardship, and increased health care
costs).2,3 Thus, there is an imperative to identify patients at
greatest risk for harm, ensure their decision-making process
regarding surgery is patient centered, and provide tailored clinical care to improve surgical outcomes in high-risk patients.
Recent data indicate that frailty is a more powerful predictor of increased perioperative mortality, morbidity, and cost
than predictions based on age or comorbidity alone.2-7 For example, when compared with robust patients, frail surgical patients are less likely to be discharged to home,6 more likely to
be readmitted to the hospital within 30 days,3,7 and more likely
to have substantially increased rates of perioperative mortality and complications.2,4,5,7,8 As such, measuring frailty substantially improves the receiver operating characteristic of predicting mortality and morbidity when compared with classic
tools, such as American Society of Anesthesiologists (ASA) classification and the Lee criteria, which systematically underestimate mortality and morbidity in high-risk populations and
are not suitable for rapid, system-level screening.5,7,9-11 However, to our knowledge, no published studies have examined
facility-wide preoperative screening for frailty aimed at improving the care and outcomes of these vulnerable surgical
patients.
The Surgical Service Line at the Veterans Affairs (VA) Nebraska–Western Iowa Health Care System (NWIHCS) in Omaha
conducts 3600 operations annually, of which 41.8% are performed in those 65 years or older. Before 2011, preoperative
risk assessment at the NWIHCS focused on traditional cardiopulmonary testing and evaluation by anesthesia. However, because of increasing postoperative mortality in 5 of 7 quarters
before July 2011, the NWIHCS chief of surgery (J.M.J.) designed and implemented a quality improvement (QI) project
called the Frailty Screening Initiative (FSI) aimed at improving postoperative survival. The FSI screened for frailty among
all patients considering elective surgery, and for those identified as frail, the FSI reviewed the surgical decision making
with surgeons, anesthesiologists, and palliative care physicians. Informed by the Standards for Quality Improvement Reporting Excellence 2 guidelines for reporting QI projects,12 we
examined the effect of the FSI on mortality and complications by comparing the surgical outcomes of a cohort of
surgical patients treated before and after implementation of
the FSI.

Methods
Context
The FSI was conducted at the NWIHCS to address a clinical need
of increased rates of case- and complexity-adjusted postoperative mortality. The NWIHCS is a large level 1b hospital at
which 3600 operations are performed per year across 12 surgical service divisions (general surgery, vascular surgery, tho234

Key Points
Question Can surgical outcomes of frail patients be improved by
facility-wide frailty screening and subsequent administrative
review of perioperative surgical decision making?
Findings After implementing a quality improvement project
called the Frailty Screening Initiative in a prospective cohort of
9153 patients who underwent surgery, postoperative mortality
decreased significantly at 30, 180, and 365 days. Multivariate
models revealed a 3-fold survival benefit after controlling for age,
frailty, and predicted mortality.
Meaning Frailty screening of preoperative patients is feasible and
may be an effective tool for improving surgical outcomes for an
aging and increasingly frail US population.

racic surgery, plastic surgery, urology, otolaryngology, ophthalmology, neurosurgery, orthopedics, oral maxillofacial,
gynecology, and podiatry). Once a patient and surgeon agree
to pursue surgery, the procedure is posted to the operating
room schedule, and the patient is referred to the surgical evaluation unit (SEU) for perioperative risk assessment and management. The workup typically focuses on cardiopulmonary
testing and optimization, but after implementing the FSI, it expanded to include frailty assessment.
The NWIHCS Institutional Review Board determined these
procedures to be an operations activity not constituting research, and thus, per Veterans Health Administration policy
(Handbook 1058.0513), the information presented in this article does not require informed consent or institutional review board approval.

Intervention
The FSI consisted of 2 parts: (1) screening for frailty with the
goal of rapid assessment without need for patient medical record access and (2) review of surgical decision making. Beginning in July 2011, all patients presenting for elective surgical
procedures at the NWIHCS were screened for frailty using the
Risk Analysis Index (RAI) as part of the standard intake examination at the outpatient surgical clinics. The RAI is a 14item questionnaire that takes less than 2 minutes to complete in a nonfrail patient, generates scores ranging from 0 to
81, and powerfully predicts postoperative mortality.14-17 To ensure adherence, the RAI score was required to schedule an operation.
Patients identified as frail (RAI score, ≥21) were flagged by
the surgical quality nurse (G.P.) for administrative review by
the chief of surgery (J.M.J.) or his designee. Reviewers included surgeons with a range of experience from senior staff
to house officers. Reviewers examined the electronic medical record of each patient identified as frail to clarify decision
making regarding surgery and optimize perioperative care. Interventions included informal discussions with the surgeons, anesthesiologists, and critical care physicians aimed at
alerting them to the patient’s frailty, the attendant risks, and
patient prognosis for 6-month mortality. When appropriate,
formal preoperative palliative care consultation focused on
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clarifying goals and expectations for the surgery and postoperative recovery, including discussions regarding ventilator dependence, dialysis, and do-not-resuscitate or do-notintubate status.
The goals of the FSI were clearly focused on assisting and
enhancing the decision making shared by surgeon and patient, and the frailty score was never used to refuse an operation that the surgeon and patient wanted to pursue. However, it is likely that the frailty diagnosis occasionally changed
the decision to operate, the choice of specific procedure, or the
anesthetic plan, although because of the operational focus of
this QI project, we were not able to capture qualitative or quantitative details about those changes. Nonetheless, the operative volume at the NWIHCS did not change substantively, suggesting that most operations proceeded as planned. In addition,
and as described previously in a subgroup analysis of this
cohort,15 the FSI significantly changed the pattern of palliative care consultation such that, after implementing the FSI,
palliative care consultation was most often ordered before
rather than after the operation and by a surgeon rather than
an intensivist or hospitalist.

Statistical Analysis
To examine the effect of the FSI, we analyzed prospectively
collected data from a cohort of patients treated at the NWIHCS from October 1, 2007, to July 1, 2014. These data were
drawn from a QI database maintained by the NWIHCS that includes multiple quality variables, including all variables abstracted through the Veterans Affairs Surgical Quality Improvement Program (VASQIP). The database constitutes a
representative sample of all the noncardiac, major elective surgical procedures conducted at the NWIHCS.18 We further linked
these data to the US Department of Veterans Affairs vital statistics file to capture dates of death for all patients who had
died.
To measure frailty in this cohort retrospectively, we
mapped VASQIP variables to each of the 14 items of the RAI
and calculated an RAI score as described elsewhere.14 We also
c alculated the modified Frailty Index as previously
described4,19 and used by others.20 We calculated the length
of survival from the date of surgery to the date of death, presuming that patients without a date of death remained alive.
Mortality rates before and after FSI implementation were compared using the Pearson χ2 tests. Two-sided P < .05 was considered significant. Multivariable logistic regression models examined the effect of the FSI on mortality, controlling for age
and frailty. For illustrative purposes, we plotted KaplanMeier survival curves stratified by RAI score for the cohorts
before and after FSI implementation, comparing the curves
with pairwise Mantel-Cox log rank tests. All analyses were conducted using SPSS statistical software, version 23 (IBM Inc).

Results
Development and testing of the FSI began in July 2010. Retrospective analysis of a cohort of patients with hip fracture revealed the RAI’s promising ability to predict postoperative morjamasurgery.com
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bidity and mortality. Pilot tests in small convenience samples
of outpatients confirmed the RAI’s ease of clinical administration. On the basis of these data, we began screening patients with the RAI in the SEU in October 2010. This approach
confirmed our ability to identify a limited group of frail patients at high risk, but we learned that screening in the SEU was
not ideal because not all patients were evaluated by the SEU
and diagnosis of frailty was delayed until after the decision for
or against surgical treatment. We therefore moved the frailty
screen upstream, deploying the RAI to select surgical clinics
in January 2011, with increasing adoption during 2 quarters.
Weekly assessment and feedback to clinics revealed increasing adherence in nearly 90% of elective surgical patients being
assessed. Given the positive feedback from the effected surgical services, we made the RAI score mandatory in July 2011:
the case scheduler was instructed to record the RAI score into
the electronic medical record, thus achieving near 100% adherence for elective surgical procedures.
Administrative review of frail patients initially focused on
clarifying the operative plan through discussion between the
reviewer and the surgeon of record. During the first 6 months,
the review rapidly expanded to include formal and informal
consultation with anesthesiologists and critical care physicians to develop plans for intraoperative and postoperative care
informed by geriatric care principles and strategies for early
recognition and treatment of expected complications (eg, rescue therapy). In addition, the reviewer recommended preoperative palliative care consultation to the surgeon of record
when the medical record did not document a clear discussion
of the patient’s goals of care or the high risk of surgery in the
setting of frailty.
The analysis includes data from a prospective cohort of
9153 patients who underwent surgery at the NWIHCS from October 1, 2007, to July 1, 2014 (mean [SD] age, 60.3 [13.5] years;
653 females [7.1%] and 7096 white [79.8%]). These patients
included all those in the local VASQIP-related QI database who
were also matched to the vital statistics file for long-term survival and mortality. Demographic characteristics of the patients treated before and after FSI implementation (July 2011)
were similar with regard to age, sex, race, ASA classification,
and comorbidity (Table 1). Most patients were not frail, with
only 6.8% scoring 21 or higher on the RAI and only 11.1% scoring higher than 0.27 on the modified Frailty Index. Patient age
and frailty were similar before and after FSI implementation
(mean [SD] age of 60.3 [13.4] years before and 60.3 [13.7] years
after, mean [SD] RAI score of 8.36 [4.86] before and 10.33 [7.38]
after, and mean [SD] modified Frailty Index score of 0.20 [0.10]
before and 0.20 [0.10] after). As expected, mortality rates increased with frailty (Table 2). For example, 180-day mortality
increased from 1.6% (113 of 7217 patients) among those with
the lowest RAI scores to 29.6% (16 of 54 patients) among those
with the highest RAI scores.
As reported in Table 3, overall 30-day mortality decreased from 1.6% (84 of 5275 patients) to 0.7% (26 of 3878 patients) (P < .001) after FSI implementation. Improvement was
greatest among frail patients (12.2% [24 of 197 patients] to 3.8%
[16 of 424 patients], P < .001), although mortality rates also decreased among robust patients (1.2% [60 of 5078 patients] to
(Reprinted) JAMA Surgery March 2017 Volume 152, Number 3
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0.3% [10 of 3454 patients], P < .001). The magnitude of improvement among frail patients increased at 180 (23.9% [47
of 197 patients] to 7.7% [30 of 389 patients], P < .001) and 365
days (34.5% [68 of 197 patients] to 11.7% [36 of 309 patients],
P < .001). Kaplan-Meier curves (Figure) reveal that increasing frailty is associated with an increased risk of death but that
these risks were significantly reduced after FSI implementation (P < .001).
Multivariable models controlling for age and RAI score revealed that postoperative survival improved at each time horizon (Table 4). To examine what portion of the effect was attributable to the intervention, we added to our model an
interaction between FSI implementation and frailty (eg, RAI
score >21). At 30 days, the interaction was not a significant predictor of mortality (P = .66), but the interaction predicted survival at 180 and 365 days (Table 4). Finally, for all but 418 patients, our data included the probability of death predicted by
the VASQIP algorithms based on patient- and procedurerelated risk factors. Adding this to our model diminished the
magnitude of the main effect slightly, but the overarching findings of the analysis remained robust after this control (Table 4),
confirming the independent role of the screening initiative in
decreasing mortality.

Table 1. Demographic Characteristics of 9153 Surgical Patients From
2007 to 2014a
No. (%) of Patients
Characteristic

Before FSI
(n = 5275)

After FSI
(n = 3878)

4876 (92.4)

3624 (93.5)

399 (7.6)

254 (6.5)

45 (0.9)

45 (1.2)

Sex
Male
Female
Race (n = 8896)
American Indian or Alaska
Native
Asian

1 (0.0)

0 (0.0)

77 (1.5)

39 (1.0)

305 (5.9)

180 (4.8)

4 (0.1)

6 (0.2)

Black or African American
Declined to answer
Native Hawaiian or Pacific
Islander
White
Unknown by patient

4042 (78.8)

3054 (81.1)

654 (12.8)

444 (11.8)

ASA class (n = 9118)
1

120 (2.3)

73 (1.9)

2

1015 (19.3)

731 (18.9)

3

3781 (72.0)

2755 (71.3)

4

334 (6.4)

299 (7.7)

5

5 (0.1)

5 (0.1)

CHF

27 (0.5)

7 (0.2)

COPD

987 (18.7)

328 (8.5)

24 (0.5)

22 (0.6)

Renal insufficiency

Discussion

Abbreviations: ASA, American Society of Anesthesiologists; CHF, congestive
heart failure; COPD, chronic obstructive pulmonary disease; FSI, Frailty
Screening Initiative.
a

Sample sizes change depending on race, ASA classification, and missing
modified Frailty Index variables.

This study reveals the feasibility of facility-wide frailty screening in elective surgical populations. It also suggests the potential to improve postoperative survival among the frail
through systematic administrative screening, review, and optimization of perioperative plans. The absolute reduction in
180-day mortality among frail patients was more than 19%,

Table 2. Prevalence of Frailty and Associated 30-Day Mortality as Measured by RAI and mFIa
Mortality, %

Variable

No. (%) in Cohort

365 d
180 d
30 d
(n = 9153 for RAI and (n = 8667 for RAI and (n = 8056 for RAI and
6638 for mFI)
6638 for mFI)
6639 for mFI)

RAI score stratum
0-10

7576 (82.8)

0.4

1.6

2.6

11-15

550 (6.0)

2.9

9.1

13.2

16-20

406 (4.4)

5.7

14.4

18.9

21-25

368 (4.0)

4.1

8.7

14.0

26-30

63 (0.7)

9.5

20.3

32.0

31-35

132 (1.4)

7.6

14.8

27.0

36-62

58 (0.6)

15.5

29.6

32.7

9153 (100)

1.2

3.3

4.9

Overall
mFI score
0.09

1932 (29.1)

0.3

1.3

1.5

0.18

2613 (39.4)

0.7

2.5

3.8

0.27

1360 (20.5)

2.4

5.7

8.0

0.36

510 (7.7)

3.9

9.2

12.0

0.45

165 (2.5)

9.1

16.4

23.6

0.55

45 (0.7)

2.2

6.7

13.3

14 (0.2)

14.3

21.4

21.4

6639 (100)

1.4

3.7

5.3

Abbreviations: mFI, modified Frailty
Index; RAI, Risk Analysis Index.
a

>0.63
Overall
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The RAI scores were calculated for
all 9153 patients and sorted into
categories. Because of missing data,
the mFI scores were calculated for
only 6639 of these patients and
sorted into categories. For each
category, the table reports the
number of patients and the
within-category mortality rate at 30,
180, and 365 days.
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Table 3. Change in Mortality Before and After Implementing the FSIa
30-d Mortality

180-d Mortality

Before FSI

After FSI

Total

Before FSI

365-d Mortality

After FSI

Total

Before FSI

After FSI

Total

Overall
No. dead
No. at risk
Mortality rate, %

84

26

110

223

66

289

320

78

398

5275

3878

9153

5275

3392

8667

5275

2781

8056

1.6

0.7

1.2

4.2

1.9

3.3

6.1

2.8

4.9

Nonfrail
No. dead
No. at risk
Mortality rate, %

60

10

70

176

36

212

252

42

294

5078

3454

8532

5078

3003

8081

5078

2472

7550

1.2

0.3

0.8

3.5

1.2

2.6

5.0

1.7

3.9

Frail
No. dead

24

16

40

47

30

77

68

36

104

No. at risk

197

424

621

197

389

586

197

309

506

Mortality rate, %

12.2

3.8

6.4

23.9

7.7

a

13.1

34.5

11.7

20.6

with a Risk Analysis Index of 21 or higher were considered frail. The number
(percentage) of frail patients was 621 (6.8%) at 30 days, 586 (6.8%) at 180
days, and 506 (6.3%) at 365 days.

Abbreviation: FSI, Frailty Screening Initiative.
Differences between mortality before and after implementing the FSI were
tested using the Pearson χ2 test. Differences were significant at every time
horizon and in every group (frail, nonfrail, and overall) at P < .001. Patients

with improvement remaining robust even after controlling for
age, frailty, and predicted mortality.
Although the initiative was aimed primarily at frail patients, improvements were noted among both frail and robust patients. This finding is likely because of a Hawthorne
effect.21,22 However, improvement was greatest among frail pa-

tients at 180 and 365 days (odds ratios, 2.19 and 1.88, respectively) but not at 30 days. This finding is significant because
the RAI was designed to predict medium-term mortality at 180
days. By identifying frail patients (eg, RAI score ≥21) and targeting interventions based on geriatric domains, it appears that
the FSI effectively mitigated the longer-term risks associated

Figure. The Effect of Frailty on Survival Before and After Frailty Screening Initiative (FSI) Implementation
B

After FSI implementation

1.0

1.0

0.8

0.8

Cumulative Survival, %

Cumulative Survival, %

A Before FSI implementation

0.6

0.4

0.2

0.6

RAI score
0-10
11-15
16-20
21-25
26-30
31-35
36-62

0.4

0.2

0

0
0

500

1000

1500

2000

2500

3000

0

200

400

Survival Length, d
No. at risk
RAI score
0-10
11-15
16-20
21-25
26-30
31-35
36-62

4654
210
214
114
21
48
14

4459
166
150
76
11
27
6

4377
160
135
66
9
24
3

3313
107
105
45
9
15
2

1537
40
75
33
4
9
1

142
3
1
3
0
0
0

0
0
0
0
0
0
0

The sample included all 9153 patients (5275 before FSI implementation and
3878 after FSI implementation). Mantel-Cox log rank tests for differences in the
survival distribution are as follows (P < .001 for overall difference before and
after FSI implementation). Before FSI implementation, the lowest 2 strata of
frailty were different from each other and from all the other strata (all P < .001).
There was no difference between the 16 to 20 and 21 to 25 Risk Analysis Index
(RAI) strata (P = .31), although the 16 to 20 RAI stratum was different from the
highest 3 strata of frailty (all P < .05). The 21 to 25 RAI stratum was not different
from the 26 to 30 (P = .16) or the 31 to 35 (P = .24) RAI stratum, but it was

jamasurgery.com

600

800

1000

1200

1178
64
53
49
9
11
8

506
27
26
17
3
5
0

0
0
0
0
0
0
0

Survival Length, d

2922
340
192
254
42
84
44

2560
261
153
224
32
71
31

2027
176
110
155
20
49
22

1707
139
83
125
13
35
18

different from the 36 to 62 RAI stratum (P = .004). Although the lines of the
highest 3 strata diverge, the differences did not reach statistical significance (all
P > .05); however, this is likely attributable to the low numbers in these RAI
strata. After FSI implementation, the lowest frailty stratum was different from
all others (P < .001), but there was no difference between the next RAI strata
(eg, 11-15, 16-20, and 21-25; all P > .20), although these 3 were different from the
top 3 strata (all P < .03). There was no difference between the top 3 strata (eg,
26-30, 31-35, and 36-62; all P > .50), but they were all different from each of the
lowest 3 strata (all P < .05). Hash marks indicate censored data.

(Reprinted) JAMA Surgery March 2017 Volume 152, Number 3
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Table 4. Multivariable Models Testing the Association of FSI Implementation With Survival, Controlling for Age, Frailty, and Predicted Mortalitya
30-d Survival
Model

180-d Survival

365-d Survival

OR (95% CI)

P Value

OR (95% CI)

P Value

OR (95% CI)

P Value

FSI implementation

4.86 (2.94-8.04)

<.001

4.02 (2.93-5.53)

<.001

4.11 (3.07-5.52)

<.001

Age

0.94 (0.92-0.96)

<.001

0.94 (0.93-0.95)

<.001

0.95 (0.94-0.96)

<.001

RAI score

0.89 (0.88-0.91)

<.001

0.90 (0.89-0.92)

<.001

0.90 (0.89-0.91)

<.001

FSI implementation

4.39 (2.53-8.54)

<.001

3.11 (2.17-4.48)

<.001

3.22 (2.31-4.48)

<.001

Age

0.94 (0.92-0.96)

<.001

0.94 (0.93-0.95)

<.001

0.95 (0.94-0.96)

<.001

RAI score

0.89 (0.87-0.91)

<.001

0.90 (0.88-0.91)

<.001

0.89 (0.88-0.90)

<.001

FSI implementation × frailty

1.24 (0.48-3.23)

.66

2.10 (1.12-3.92)

.02

2.08 (1.16-3.73)

.01

FSI implementation

3.55 (1.80-7.02)

<.001

2.87 (1.98-4.16)

<.001

2.97 (2.11-4.19)

<.001

Age

0.94 (0.92-0.96)

<.001

0.95 (0.93-0.96)

<.001

0.95 (0.94-0.96)

<.001

RAI score

0.90 (0.88-0.93)

<.001

0.90 (0.89-0.92)

<.001

0.90 (0.89-0.92)

<.001

FSI implementation × frailty

1.41 (0.49-4.08)

.53

2.19 (1.11-4.32)

.02

1.88 (1.00-3.55)

.051

0.06 (0.01-0.33)

.001

0.04 (0.01-0.13)

<.001

0.03 (0.01-0.09)

<.001

Model 1

Model 2

Model 3

Predicted mortality

Abbreviations: FSI, Frailty Screening Initiative; OR, odds ratio; RAI, Risk Analysis
Index.
a

For the interaction between FSI implementation and frailty, patients were
considered frail if they had RAI scores of 21 or higher. Sample sizes for models 1
and 2 were 9153, 8667, and 8056 for the 30-day, 180-day, and 365-day

with frailty itself. This finding also suggests that it takes more
than 30 days to detect the effect of these interventions, further delineating the limitations of 30-day outcomes noted by
others.23,24
The ultimate cause of the survival benefit is likely multifactorial, including changes in preoperative decision making,
intraoperative management, and postoperative rescue. A consensus panel outlined several potential targets for improving
the perioperative management of frail patients, including
frailty-specific anesthetic plans, clarified goals of care identified in the preoperative setting, and improved postoperative
management.25 Postoperative rescue therapy deserves specific consideration. Research reveals that major complications occur in 40% of frail patients after major operations, and
thus frail patients frequently require attempts at rescue from
those complications.20 By identifying frail patients at greatest risk for complications, the FSI may have raised the vigilance of clinicians to recognize those complications earlier and
treat them more effectively. In addition, we suspect that increasing reliance on preoperative palliative care consultation
and formal, preoperative documentation of goals may have improved the rate of rescue by better delineating the patient’s expectations regarding rescue therapies, such as ventilator management or dialysis in the immediate postoperative period. In
fact, on more than one occasion, NWIHCS clinicians described situations when a patient became incapacitated from
a complication in the postoperative period: the surrogate decision maker initiated conversations about withdrawal of care,
but the palliative care consultant’s note clearly stated the patient’s intention to pursue aggressive rescue therapies for at
least a time-limited trial. Having these expectations well documented by somebody other than the surgeon may help build
238

survival groups, respectively. Because 418 patients were missing data on the
predicted mortality based on Veterans Affairs Surgical Quality Improvement
Program algorithms, the sample sizes for model 3 were 8735, 8249, and 7638
for the 30-day, 180-day, and 365-day survival groups, respectively.

consensus among patients’ families and clinicians, thus giving rescue therapies adequate time to treat some of the survivable complications that frail patients predictably incur. Finally, on the basis of improvement in survival not only at 30
days but also at 180 and 365 days, we suspect postdischarge
care and social support were also improved through engagement of the family in the entire operative process, including
long-term recovery.
Although our data cannot quantify how the FSI changed
perioperative decision making, it is likely that some frail patients did not undergo surgery and are thus not included in this
analysis. This potential selection bias could explain some of
the effect. However, the mean frailty of the cohort after FSI
implementation was actually higher than that in the cohort before FSI implementation (mean RAI scores, 10.33 vs 8.36), suggesting that many frail patients continued to seek and secure
surgical treatment—even in light of preoperatively diagnosed
frailty. In a previously published subgroup analysis of 310 of
these patients receiving palliative care consultations, we controlled for whether patients underwent surgery, and the survival benefit remained robust (odds ratio of dying after FSI
implementation, 0.37; 95% CI, 0.22-0.62).15
These results also provide estimates of the likely rates of
postoperative mortality over time at different levels of frailty,
and these estimates have potential to inform the shared decision making between surgeons and patients. For example, patients with RAI scores between 26 and 30 have associated mortality risks of 20.3% at 6 months, increasing to 32.0% at 1 year.
The associated 30-day mortality of only 9.5% might be perceived as a better than 90% chance of survival, and thus surgeons and patients alike might persevere with surgical treatment. However, with these reliable estimates of longer-term
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mortality, it is likely that some patients will consider the risks
too great and forgo surgery. Such longer-term mortality estimates are critical for shared decision making when the time
to treatment equipoise 26 for the proposed surgery approaches or exceeds the patient’s expected life span.
From a systems perspective, frailty screening with the RAI
has many advantages. First, because the RAI is based on the
deficit accumulation frailty model, it is easier to operationalize than functional assessments, such as the Fried frailty
phenotype.27 However, because it includes 10 elements of the
Canadian Study of Health and Aging Frailty Index and because a similarly abbreviated version of the Canadian Study
of Health and Aging Frailty Index had excellent predictive
ability and discrimination compared with the Fried frailty
phenotype,27 it is likely that the RAI will also perform on par
with functional assessments of frailty. Second, because the
RAI encompasses multiple domains of frailty (comorbidity,
functional status, nutrition, and cognition), it represents a
more comprehensive frailty assessment than the modified
Frailty Index, the other deficit accumulation model of
frailty validated in surgical populations that only includes
domains of comorbidity and functional status. Third, the
RAI is the only surgical frailty measure to look beyond 30
days, predicting longer-term outcomes to 1 year. Fourth, the
current study reveals the ability to screen entire populations
of surgical patients with a precision that makes it flexible for
clinical use.

Limitations
Our findings are limited in several ways. Most important, although we were able to control for frailty, we were unable to
account for patients who screened as frail and did not undergo surgery. This limitation may be a source of significant
selection bias, although it is clear that surgeons continued to
operate on frail patients. Further research using a randomized controlled design will be necessary to establish the causal
connection between the FSI and mortality outcomes. In addition, our QI intervention did not adhere to a formal postoperative intervention or prehabilitation protocol, thus limiting
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our ability to infer the causative factor behind improvement.
Further research is required to standardize the approach and
discern which parts of the intervention are essential and influential. The generalizability of our findings is limited to a
single Veterans Affairs medical center, although the characteristics of the cohort appear comparable to other Veterans Affairs populations. Last, although survival improved, we know
little about the quality of the surviving life. Future studies must
confirm this assumption by assessing patient-centered outcomes, such as quality of life and the patient-centeredness of
decisions.

Conclusions
To our knowledge, this is one of the first studies to document
the feasibility of facility-wide screening of frailty and how
implementation of an FSI is associated with improved survival at 30, 180, and 365 days. We also found that the RAI predicts postoperative mortality, with an initial calibration of the
RAI to predict mortality among elective surgical patients within
a Veterans Affairs population. Depending on the threshold chosen, the RAI identifies 5% to 20% of the population as potentially frail, and although further research is needed, there are
several plausible interventions to improve outcomes among
the frail through prehabilitation,28,29 patient-centered decision making,15 and rescue therapy. This project is timely in the
changing health care environment, which incentivizes valuebased care deployed to enhance population health. Hospitals
and surgeons are looking for replicable models that can efficiently use existing resources and improve the quality and
safety of surgery in a rapidly aging population. This study builds
a platform for further investigation into the causal connections and mechanisms behind improved survival after systematic frailty screening in preoperative populations. The sustainability of FSI in the long term and implementation in
different settings will depend on integration with clinical workflow, use of electronic medical records, and standardization
of intervention for frail patients.
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Invited Commentary

A Call for Frailty Screening in the Preoperative Setting
Anne M. Suskind, MD, MS; Emily Finlayson, MD, MS

Frailty is associated with an increased risk of undesirable postoperative outcomes across surgical subspecialties, including complications, length of stay, discharge to a skilled or assisted-living
facility,1-3 and morbidity.4 With
the rapidly increasing older
Related article page 233
population, frailty assessment
in the preoperative setting is
becoming an increasingly important, yet rarely performed,
screening tool that is recommended by both the American College of Surgeons and the American Geriatric Society.5
240

In this issue of JAMA Surgery, Hall et al6 share their experience with the implementation of the Frailty Screening Initiative at a Veterans Affairs medical center. They used the Risk
Analysis Index, which is a deficit accumulation model of frailty,
to identify frail individuals to undergo further review before
their anticipated operation. Compared with a historical control of patients in the same medical center before implementation of the Frailty Screening Initiative, patients who underwent frailty screening had a decrease in overall mortality from
1.6% to 0.7%. However, this decrease was most pronounced
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